FDA cracks down on drugs ads, promises to end adequate provision ‘loophole’
Regulatory NewsJoanne S. Eglovitch
Advertising, Promotion and LabelingPharmaceuticalsRegulatory Intelligence/PolicyRegulatory strategySafety communicationUnited StatesUS Food and Drug Administration (FDA)